IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (129)	11/22/1996 12:03:00 AM
From: I. Luttichuys	of 1762

Good evening Brad, I just wanted to thank you for your take on the information kindly provided by F.S. Wang. I does seem very exciting. F.S. Wang specifies that the 60/40 efficacy reflects patients who "completed the study". The 66/60 difference between March and today could be even due to minor changes in number of patients in study as well I suppose. In addition, if it is shown that efficacy of C2B8 as a stand-alone therapy is good and that C2B8/CHOP is excellent as well, I think this would indeed be very exciting news. I look forward to your receiving this abstract, BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next